{"DataElement":{"publicId":"6063577","version":"1","preferredName":"Intervention or Procedure Prostate Carcinoma Histologic Confirmation Performed Type","preferredDefinition":"A response used to indicate the procedure used to verify the class of the most common type of malignant tumors afflicting men that arises in the prostate gland by identifying the common qualities in the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","longName":"6063566v1.0:6063562v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"6063566","version":"1","preferredName":"Intervention or Procedure Prostate Carcinoma Histologic Confirmation Performed","preferredDefinition":"An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects._One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.  -- 2002_Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._Having been established or verified._Executed and carried through to completion.","longName":"2233215v1.0:6063564v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"2233215","version":"1","preferredName":"Procedure","preferredDefinition":"A particular course of action intended to achieve a result.","longName":"C25218","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intervention or Procedure","conceptCode":"C25218","definition":"An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9313AE8-B7EE-4260-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"ONEDATA","dateModified":"2005-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6063564","version":"1","preferredName":"Prostate Carcinoma Histologic Confirmation Performed","preferredDefinition":"One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.  -- 2002:Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.:Having been established or verified.:Executed and carried through to completion.","longName":"C4863:C25526:C25458:C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Carcinoma","conceptCode":"C4863","definition":"One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A67877-B36C-4AAC-E053-F662850AB628","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A67877-B37D-4AAC-E053-F662850AB628","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-03-01","changeDescription":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6063562","version":"1","preferredName":"Prostate Cancer Histology Method Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6063562v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Radical prostatectomy","valueDescription":"Radical prostatectomy","ValueMeaning":{"publicId":"2571933","version":"1","preferredName":"Radical prostatectomy","longName":"2571933","preferredDefinition":"Surgery to remove the entire prostate. The two types of radical prostatectomy are retropubic prostatectomy and perineal prostatectomy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radical Prostatectomy","conceptCode":"C15399","definition":"The surgical removal of all of the prostate as well as some surrounding tissue, including lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E60A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-16","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64A3A216-6378-064B-E053-F662850A26CB","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"Needle biopsy of prostate","valueDescription":"Needle Biopsy of Prostate","ValueMeaning":{"publicId":"2794444","version":"1","preferredName":"Needle Biopsy of Prostate","longName":"2794444","preferredDefinition":"Removal of tissue from the prostate for microscopic examination, using a needle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Needle Biopsy of Prostate","conceptCode":"C51694","definition":"Removal of tissue from the prostate for microscopic examination, using a needle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"59F04A64-E1D8-590B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"LEEB","dateCreated":"2008-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64A3A216-638C-064B-E053-F662850A26CB","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"Biopsy of metastasis","valueDescription":"Biopsy Metastasis","ValueMeaning":{"publicId":"6063563","version":"1","preferredName":"Biopsy Metastasis","longName":"6063563","preferredDefinition":"The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.: The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biopsy","conceptCode":"C15189","definition":"The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Metastasis","conceptCode":"C19151","definition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A3A216-6399-064B-E053-F662850A26CB","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64A3A216-63B4-064B-E053-F662850A26CB","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64A3A216-63BE-064B-E053-F662850A26CB","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A3A216-6361-064B-E053-F662850A26CB","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-03-01","changeDescription":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"5936696","version":"1","longName":"Disease Assessment ","context":"ECOG-ACRIN"},{"publicId":"5936697","version":"1","longName":"Method of Evaluation","context":"ECOG-ACRIN"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Method of histologic confirma","type":"Preferred Question Text","description":"Method of histologic confirmation","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A4969D-594F-46D4-E053-F662850A8F09","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeDescription":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}